Title: Sodium deoxyribonucleotide injection at Zusanli point for chemotherapy-induced leukopenia in patients with lung cancer
Abstract: Objective
To evaluate the therapeutic effect of sodium deoxyribonucleotide injection at Zusanli point for chemotherapy-induced leukopenia in patients with lung cancer.
Methods
A total of 116 chemotherapy-induced leukopenia patients with lung cancer were randomly divided into a therapy group and a control group, 60 in the treatment group and 56 in the control group. The patients in the treatment group were treated with sodium deoxyribonucleotide injection at Zusnli point, and those in the control group were treated with vein injection of sodium deoxyribonucleotide.
Results
The total effective rate in the treatment group was significant higher than that in the control group (91.7% vs.76.8%; χ2=4.890, P=0.032). The effective rates on days 3,5,7 and 10 in the treatment group were also significant higher than those in the control group (on day 3: 51.7% vs. 32.1%, χ2=4.530, P=0.036; on day 5: 76.7% vs. 53.6%, χ2=6.840, P=0.018; on day 7: 85.0% vs. 67.9%, χ2=4.770, P=0.026; on day 10: 78.3% vs. 53.6%, χ2=7.960, P=0.011).
Conclusion
Sodium deoxyribonucleotide injection at Zusanli point has definite efficacy for chemotherapy-induced leukopenia in patients with lung cancer.
Key words:
Leukopenia; Antineoplastic agents; Lung neoplasms; Point ST36(Zusanli); Deoxyribonucleotides; Point injection
Publication Year: 2015
Publication Date: 2015-07-30
Language: en
Type: article
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot